• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Biotechnology’s Role in Improving Stroke Outcomes

    CEO Spotlight: Marc Kikuchi

    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Novavax Submits EUA for Protein-based COVID-19 Vax Booster

    BeiGene, Ontada Enter Strategic Oncology Alliance

    AskBio Appoints Clinical Ops Executives

    SpectrumX Partners With UK Contract Manufacturer

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    SpectrumX Partners With UK Contract Manufacturer

    Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership

    Almac Invests $65M to Expand North American HQ

    Captor Therapeutics Selects CDMO for Clinical Trial Materials

    Catalent to Acquire Metrics Contract Services for $475M
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    UPS to Acquire Healthcare Logistics Provider Bomi Group

    Marken to Acquire Medical Courier Business of Cedra Express

    5 Key Features of Agile Pharmaceutical Packaging Supply Chains That Drive Results

    Novavax Expands Manufacturing Agreement with SK bioscience

    Lonza Continues to Lead the Market with Innovative Hard Empty Capsules
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Novavax Submits EUA for Protein-based COVID-19 Vax Booster

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth

    West Pharmaceutical Makes Strategic Investment in Latch Medical

    “3 Key Trends” with James Park

    Captor Therapeutics Selects CDMO for Clinical Trial Materials
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Chime Biologics Receives Commercial Manufacturing License

    Automation Is Key to Meeting Demands in Pharmacovigilance

    UBC Acquires Examoto

    Responding to Consumer Complaints While Working with CMOs

    WuXi Vaccines Receives GMP Certificate from HPRA
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Quotient Sciences

    Aphena Pharma Solutions

    Vector Partners Limited

    CMC Pharmaceuticals

    IDT Biologika
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Quotient Sciences

    Aphena Pharma Solutions

    Vector Partners Limited

    CMC Pharmaceuticals

    IDT Biologika
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Why Regulatory Changes Matter in APAC

    FDA is increasing inspections in Asia as more and more generics are being made there

    Related CONTENT
    • CPhI North America Event Info
    • Samsung Biologics
    • Tower Cold Chain to Open New Global Headquarters in the UK
    • Aurion Biotech Makes Strategic Investments in Manufacturing
    • Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies
    Warren Perry, Dassault Systu00e8mes BIOVIA09.11.15
    As the pharmaceutical/biologics industry continues to grow in the Asia-Pacific (APAC) region, more and more life sciences companies there are looking to export products—especially to meet high demands for generic drugs. To do so, they will need to pass inspections by international regulatory agencies, including the U.S. Food & Drug Administration (FDA) and the European Medicines Agency (EMA). Being prepared for stricter regulatory scrutiny provides revenue opportunities and other benefits for those companies that are willing to invest in stepped-up compliance.

    With U.S. policymakers striving to achieve more affordable healthcare, demand for less-expensive generic drugs has increased to represent 80% of the drugs prescribed.1 The vast majority of generics are manufactured outside of the U.S.—in China and India primarily. Thus, the FDA is increasing its inspections there.

    This forces APAC-based, along with all other global, drug companies who want to seize U.S. market opportunities to comply with requirements outlined in the 2012 Generic User Fee Act, which generates dollars to help the FDA hire more foreign inspectors and update technology to accept electronic submissions by May 2017. At the same time, API and biologics manufacturers, contract manufacturing organizations (CMOs) and contract research organizations (CROs) also are regularly audited by their international client base who need to ensure they are in compliance. Generic producers across the supply chain who can’t pass inspections in time risk having to go out of business—especially as the generics market becomes increasingly competitive and consolidates. 

    Ultimately, allocations from the new user-fees will enable FDA inspectors to visit foreign drug manufacturing facilities every two years using risk-based methodologies. So it’s now more crucial than ever that all companies in the global supply chain comply with FDA specifications and the Good Manufacturing Practice (GMP) regulations, and that these specifications are met electronically.
    To comply, drug manufacturing sponsors and their partners must change the way they operate and the way they collect and transfer data. This idea of data transfer covers all aspects of the supply chain, such as certificates and quality information, which can evolve over months of data collection. Most of this data is created outside of the final producer’s firewall, which poses a whole new set of obstacles. Technology to move through the firewall in a controlled way needs to be part of any solution.

    The biggest challenge for the APAC drug companies and their suppliers is financial. Profit margins on generics are among the industry’s slimmest, with consumers benefitting from discounts of 27-49% of list price.1 As a good example, a China-based CMO might contribute only 10% of its output into products sold in the U.S. through various customers’ supply chains. New regulatory standards still apply to this company—whether it’s selling 1% or 99% to the U.S. It will have to decide if it wants to be exempt—and not sell to U.S.—or only sell into supply chains that end in APAC, minus Japan, which also has more stringent inspections. If this company chooses to sell into the U.S., it needs to fully understand the ramifications of chasing that potentially rewarding market.
    The short-term ramification means large investments, but the benefits include a strong competitive advantage. Having the right document management systems in place meets demands from more sophisticated sponsors who want controlled, audited environments to exchange information across their supply chains—from research phases through commercialization. The contractor who can deliver Part 11 compliant data, quickly available for audits and inspections, stands to gain more business.

    The example CMO that does choose to invest in electronic document management systems also should see improved efficiencies with reliable regulatory compliance and better quality. In the quality assurance arena, its users need a solution that allows for strong version control and audited distribution of standard operating procedures (SOPs), specifications, protocols, batch records, and customer agreements to ensure only the latest versions are in circulation and users across global manufacturing networks are properly trained on the correct procedures.

    Best practices are emerging around the world for putting such compliance and quality management systems in place quickly and effectively to keep current with GMPs in 2015 and beyond. One example is cloud-based solutions that benefit global supply chains, from early drug development through dispersed manufacturing and advanced commercialization.

    As an illustration, one U.S.-based generic pharmaceutical company with sites across multiple countries, including APAC, produces hundreds of drugs in its roles as an original manufacturer, a CMO and a CRO. It uses an electronic document management system to support compliance across the European Union (EU), FDA and APAC. Automated, efficient access to data used for Annual Product Reports (APRs), audits, change controls and work flows, to name a few, are critical in today’s competitive world.

    Incorporating these systems as part of its statement of work (SOW) with all partners ensures overall benefits are realized, including:
    • Improved compliance, such as electronic access to updated SOPs and readily available documentation for inspections and customer audits;
    • Time savings, including e-signatures for workflows and speedier regulatory approvals; and
    • Cost savings, realized from achieving quality in new markets without hiring additional employees and accelerating product launches to add revenue streams.
    As companies and their global partners move to compliant, electronic quality management systems it’s also important to recognize the requirements such systems place on organizations and manufacturing networks. These can include not only human and financial resources, but the need for organizations to become “change-ready” in order to use these systems as part of the culture of quality, rather than viewing these changes as a burden. 

    In the end, it’s not only change-ready APAC supply chain members who embrace new technology that stand to benefit from new regulations and scrutiny. Whether you are a consumer of drugs in the U.S., or elsewhere in the world, or a drug manufacturer relying on foreign factories, it’s clear that as more companies step-up to comply with FDA requirements, a much safer and reliable drug supply chain will emerge to keep pace with global demands. 

    References
    1. www.fda.gov


    Warren Perry has been with QUMAS, now BIOVIA for over twelve years. During this time he has held various positions including Product Marketing Manager, Marketing Manager and Project Lead. Warren has years of experience working for European software companies, and an understanding of global markets in GRC, Regulatory Publishing and EDMS systems, having worked with clients such as Takeda, Samsung Biologics, Roche, Boehringer Ingelheim, GlaxoSmithKline, Fidelity Investments, Bank of America, Logica CMG and Aspen Pharmaceuticals.
    Related Searches
    • Contract Research
    • CRO
    • CMO
    • API
    Suggested For You
    CPhI North America Event Info CPhI North America Event Info
    Samsung Biologics Samsung Biologics
    Tower Cold Chain to Open New Global Headquarters in the UK Tower Cold Chain to Open New Global Headquarters in the UK
    Aurion Biotech Makes Strategic Investments in Manufacturing Aurion Biotech Makes Strategic Investments in Manufacturing
    Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies
    Emergent BioSolutions, Providence Therapeutics Enter Vaccine Manufacturing Partnership Emergent BioSolutions, Providence Therapeutics Enter Vaccine Manufacturing Partnership
    Trust, but Verify Trust, but Verify
    Planning For Better Clinical Trials Planning For Better Clinical Trials
    Raman Spectroscopy for Pharmaceutical Analysis & Quality Control Raman Spectroscopy for Pharmaceutical Analysis & Quality Control
    Inhaled Drug Delivery Trends Inhaled Drug Delivery Trends
    Clinical Trial Kitting Clinical Trial Kitting
    Maintaining Critical Drug Supply During COVID-19 Maintaining Critical Drug Supply During COVID-19
    Partnering with a CDMO for Orphan Drug Development Partnering with a CDMO for Orphan Drug Development
    Choosing and Managing a CDMO Choosing and Managing a CDMO
    Putting Laboratory Suppliers to the Test in the COVID Era – and Beyond Putting Laboratory Suppliers to the Test in the COVID Era – and Beyond

    Related Live From Shows

    • CPhI North America Event Info

      CPhI North America Event Info

      ...
      04.21.22

    • Samsung Biologics

      Samsung Biologics

      ...
      Yeyoung Kim, Global PR Specialist 12.02.21

    • Breaking News | Cold Chain Management | Facilities | Industry News | Packaging & Tracking
      Tower Cold Chain to Open New Global Headquarters in the UK

      Tower Cold Chain to Open New Global Headquarters in the UK

      The 26,000 sq. ft building will greatly expand Tower’s container conditioning and storage capacities.
      09.16.21


    • Breaking News | Industry News | Promotions & Moves
      Aurion Biotech Makes Strategic Investments in Manufacturing

      Aurion Biotech Makes Strategic Investments in Manufacturing

      Appoints Tim Largen as VP of manufacturing to drive cell therapy production strategy and direct collaborations with leading CDMOs.
      09.14.21

    • Drug Development | Laboratory Testing
      Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies

      Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies

      The importance of reagent quality control, especially endotoxin testing, during CGT development and the selection of reagents and suppliers to ensure safety.
      Garrett Perry, Technical Services Specialists at Teknova 09.14.21

    Loading, Please Wait..
    Trending
    • Novavax Submits EUA For Protein-based COVID-19 Vax Booster
    • Gilead Sciences To Acquire MiroBio For $405M
    • Thermo Fisher Expands NY Cell Culture Media Manufacturing Site
    • Almac Invests $65M To Expand North American HQ
    • Pfizer, Neurocrine Terminate Collaboration
    Breaking News
    • Novavax Submits EUA for Protein-based COVID-19 Vax Booster
    • BeiGene, Ontada Enter Strategic Oncology Alliance
    • AskBio Appoints Clinical Ops Executives
    • GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    • SpectrumX Partners With UK Contract Manufacturer
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Biotechnology’s Role in Improving Stroke Outcomes
    • CEO Spotlight: Marc Kikuchi
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    Indorama Ventures Posts Record 2Q 2022 Results
    Advanced Polymer Coatings Strikes Series of New Tanker Deals
    Barentz Named Distributor for Pilot Chemical Segments in US and Canada
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Spartech Promotes Three Staff Members
    Elisabeth Lackner Named Chief Scientific Officer at Element Materials Technology
    Natech Plastics Purchases Three New Injection Molding Machines
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Novavax Submits EUA for Protein-based COVID-19 Vax Booster
    BeiGene, Ontada Enter Strategic Oncology Alliance
    AskBio Appoints Clinical Ops Executives
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Mary Kay Supports International Women's Forum's Latest Research
    Vegamour Launches in the UK
    Maelys Rolls Out to Ulta Beauty
    Happi

    Latest Breaking News From Happi

    Dr. Bronner’s Releases 2022 All-One! Report, ‘Leading with Heart’
    In-Cosmetics Asia Returns to Bangkok to Deliver Look at Market Trends and Ingredient Innovations
    Perfect Corp. AI Skin Analysis Beauty SaaS Brand Console Is HIPAA-Compliant
    Ink World

    Latest Breaking News From Ink World

    BASF Breaks Ground on Riverfront Park in East Newark
    Roland DG Corporation to Relocate HQ to Miyakoda, Japan
    Gallus Launches Gallus One, Its First Fully Digital Inkjet Label Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Color-Logic partners to feature metallics at autumn events
    New Era Converting Machinery heads to The Battery Show
    Cyngient, Imageworx partner at Labelexpo for security labeling innovation
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Daio Paper Acquires Pet Care Products Manufacturer
    Honest Reports Increased Revenue
    Weekly Recap: Essity Switches to Recyclable Packs for Feminine Pads, FTC Sues PPE Maker on False Origin Claims & More
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FundamentalVR Raises $20 Million in Series B Funding
    Bioventus Achieves Strong Growth in Q2 2022
    Bone Void Fillers Market Growing at 6%
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    onsemi Celebrates Expansion of Silicon Carbide Production Facility in New Hampshire
    Applied Materials CTO Dr. Om Nalamasu Receives IEEE Frederik Philips Award
    Weekly Recap: ALTANA, Universal Display and Emerson Top This Week’s Stories

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login